Synthetic Minds Newsletter

Synthetic Minds | Your Money Is Turning Into Software Anyone Can Issue

A major European bank has issued a euro you can hold as a token, a cash fund has moved onto a public blockchain, and 140 firms have unveiled a shared digital dollar. Everyday money is becoming software that a bank, a company, or a government can issue, and the safety net was built for the old kind.

Synthetic Minds | AI Labs Are Rebuilding Science on Private AI

software company with no lab has started designing its own medicines, a Nobel-winning AI is entering human trials, and Japan calls AI-for-science a matter of sovereignty. AI has become the operating system of discovery, much of it privately owned. Leaders must ask who owns the knowledge it makes.

Synthetic Minds | AI Has Gone From Advising to Prescribing Medication

An FDA-cleared AI agent has begun altering patients' medication inside major US hospitals, the government funds one that manages heart care, and algorithms already shape what insurers cover. The AI in medicine has moved from advising the human decision to making it. No one has settled who is liable.

Synthetic Minds | What the Outside Can't See About Your AI Readiness

A public-record assessment can only judge what you have published. I ran exactly that on six of the largest companies in the world, and the results were unflattering. But the uncomfortable part is not the six cards. It is what they cannot see.

Synthetic Minds | Frontier AI Went Open, And It Cannot Be Closed Again

Frontier AI is escaping the closed lab. A community-funded medical lab and a free, MIT-licensed model that out-hacks closed systems reveal one shift: capability has decoupled from price, permission and the export license. The cure and the exploit ride the same rails, and neither one can be recalled.

Synthetic Minds | Clean Power Becomes Software. Who Holds The Switch?

A ceramics group handed fifteen plants to an AI platform. A geothermal developer is building a software twin of its wells. Clean power is becoming dispatchable-by-software, and the brain inside each asset answers to its vendor, not the operator or a regulator. Leaders should ask who holds the switch

Synthetic Minds | The Human Body Has Become The Dataset. Who Owns It?

Robots will not move, and medical AI will not read a room, until they have watched millions of us work. So the cameras have spread: forehead cameras on garment workers, recorders in exam rooms, black boxes in operating theaters. The human body has become the dataset, and the question is who owns it.

Synthetic Minds | Are Carmakers Quietly Becoming Humanoid Makers?

Hyundai has bought Boston Dynamics outright, and China's carmakers are racing into humanoids, too. The reason is structural: robotaxis will undercut car ownership, car demand will soften, and the factory — not the car — is the asset that transfers to a humanoid market analysts size in the trillions.

Synthetic Minds | AI's Biggest Bet is that Compute Stays Scarce Forever

Amazon's researchers found a flaw in Anthropic's most powerful AI. Amazon CEO Andy Jassy phoned the US Treasury Secretary Scott Bessent. The Commerce Department then ordered Anthropic to switch off its two best AI models for everyone outside America. Amazon funds Anthropic and hosts it on its cloud.

Synthetic Minds | Surgery, Drugs and Biosecurity Share the Same Brain

Nvidia has shipped the first commercially licensed surgical AI brain to robot makers. Jazz Pharmaceuticals has committed up to $2.46 billion and Merck up to $510 million to two AI antibody platforms. BARDA has closed its window on AI antivirals. The substrate of medicine has been quietly outsourced.